AcquisitionOther
Entasis Therapeutics Holdings Inc. acquired Entasis Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Entasis Therapeutics Holdings Inc. -> Entasis Therapeutics · $2.20
“This acquisition will build upon our overall strategy to acquire differentiated, high-potential assets in attractive, yet often overlooked, disease areas where our capital and capabilities can make a difference,” said Pavel Raifeld, Chief Executive Officer of
Open source record (SEC) ↗